Eric Lefkofsky, the Philanthropist

He is the co-founder and also the CEO of Tempus, a company that aims to put in place databases that calibrate cancer treatment. According to him, to fight cancer successfully, the doctors will have to get a data bank that will avoid confusion in the treatment and give a clear picture of cancer patients.The patient information is required in the sector and is available. There is little resources that will combine genomic data and therapeutic information. Eric has been observing this and brought it into the light at the Fortune Brainstorm Health Conference in San Diego.In the conference, he stated the need of having molecular, therapeutic and outcome response data will give a clue on how the treatment works so that it can be seen if efficient or not. The genetic information will not be taken into strict consideration.

The scientists are doing a breast cancer research with patients using Herceptin and looking for a reason as to why 40% percent respond to it. They should make an effort to know why the 60% do not respond. Are they diabetic or use a counter-drug that does not conform with the Herceptin. The people looking for data on the drug will have a hard time getting data. They would be told to wait for a long period of 90 days and yet if the data was uploaded in the health system it was going to make work easier.Eric was then compelled to come up with the Tempus when the wife was diagnosed with breast cancer. He said that it would be easier to find a drug that is effective if the data is combined and compared among the patients. It will help solve the cancer problem that is killing a lot of people.

His company will build a better version of the electronic medical record EMR that will combine a fresh data and feed the clean version back to the source so that it can validate and verify information. Oncologists and neurological doctors will have a base to start treatment by helping Research scientists in finding personalized vaccines using this data.Lefkofsky’s philanthropy is evident in other sectors like arts and culture, education and human rights.